AMERICAN CALCIGLU (Equivalent of 10% Calcium Gluconate) INJECTION 2 x 5x 10ml

AMERICAN CALCIGLU (Equivalent of 10% Calcium Gluconate) INJECTION 2 x 5x 10ml Generic Name: Calcium Gluconate Brand Name: American Calciglu Class: Mineral supplement, Calcium therapy Pack Size: 2 Packs (each containing 5 ampoules of 10ml solution) Strength: 10% Calcium Gluconate (100 mg/ml) Amount: ₦6,200. Description: AMERICAN CALCIGLU is a sterile, non-pyrogenic solution containing Calcium Gluconate, a calcium salt used primarily for treating conditions associated with low calcium levels in the blood. The solution is equivalent to 10% Calcium Gluconate, providing essential calcium ions crucial for various physiological functions, including muscle contraction, bone formation, and nerve conduction. Each package contains 2 sets of 5 ampoules, each with a 10ml solution. Key Features: • High Purity: Contains 10% Calcium Gluconate, offering a reliable source of calcium ions. • Versatile Use: Suitable for treating hypocalcemia, tetany, and other conditions requiring rapid calcium replenishment. • Convenient Packaging: Comes in ampoules, ensuring sterility and accurate dosing. • Rapid Action: Provides immediate calcium supplementation in acute situations. Side Effects: Common side effects may include: • Injection site reactions (pain, redness, swelling) • Feeling of heat waves • Tingling sensations Less common but serious side effects: • Hypotension (especially with rapid infusion) • Cardiac arrhythmias • Hypercalcemia (symptoms may include nausea, vomiting, constipation, and confusion) Caution: • Intravenous Use Only: Ensure proper dilution and slow administration to avoid complications. • Monitoring: Regular monitoring of calcium levels is necessary to avoid hypercalcemia. • Contraindications: Not to be used in patients with hypercalcemia, ventricular fibrillation, or severe renal insufficiency. • Drug Interactions: May interact with other medications, such as cardiac glycosides (e.g., digoxin) or calcium channel blockers. • Special Populations: Use caution in patients with a history of renal impairment, cardiac disease, or in those receiving digitalis.